Neupharma, Inc.
Records under this name other than the patents Neupharma, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 35 patents it holds.
Showing 1 to 6 of 6 · Back to Neupharma, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,047,059 | Substituted Quinoxalines for Inhibiting Kinase Activity Lapsed on the fee record Ended Aug 14, 2026 · Medium confidence | Lapsed on the fee record | Ended Aug 14, 2026 | Medium confidence |
| US 8,691,977 | Certain chemical entities, compositions, and methods Lapsed on the fee record Ended Apr 8, 2026 · From the USPTO record | Lapsed on the fee record | Ended Apr 8, 2026 | From the USPTO record |
| US 9,908,866 | Certain chemical entities, compositions, and methods Lapsed on the fee record Ended Mar 6, 2026 · From the USPTO record | Lapsed on the fee record | Ended Mar 6, 2026 | From the USPTO record |
| US 8,614,211 | Certain chemical entities, compositions, and methods Lapsed on the fee record Ended Dec 24, 2025 · From the USPTO record | Lapsed on the fee record | Ended Dec 24, 2025 | From the USPTO record |
| US 9,707,202 | Certain chemical entities, compositions, and methods Lapsed on the fee record Ended Jul 18, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jul 18, 2025 | From the USPTO record |
| US 9,328,081 | Certain chemical entities, compositions, and methods Lapsed on the fee record Ended May 3, 2024 · From the USPTO record | Lapsed on the fee record | Ended May 3, 2024 | From the USPTO record |